Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial
出版年份 2019 全文链接
标题
Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial
作者
关键词
Non-alcoholic fatty liver disease, Nano-curcumin, Obesity, Overweight, Iran
出版物
Nutrition & Metabolism
Volume 16, Issue 1, Pages -
出版商
Springer Nature
发表日期
2019-01-28
DOI
10.1186/s12986-019-0331-1
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Curcumin and other dietary polyphenols: potential mechanisms of metabolic actions and therapy for diabetes and obesity
- (2018) Tianru Jin et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Effect of Curcumin on Anthropometric Measures: A Systematic Review on Randomized Clinical Trials
- (2018) Mitra Hariri et al. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
- Curcumin or combined curcuminoids are effective in lowering the fasting blood glucose concentrations of individuals with dysglycemia: Systematic review and meta-analysis of randomized controlled trials
- (2018) Ingrid Sofia Vieira de Melo et al. PHARMACOLOGICAL RESEARCH
- Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled clinical trial
- (2018) Milad Daneshi-Maskooni et al. Nutrition & Metabolism
- The protection effects of (1E,6E)-1,7-diphenylhepta-1,6-diene-3,5-dione, a curcumin analogue, against operative liver injury in rats
- (2017) Xiaowei Chi et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Artemisia iwayomogi plus Curcuma longa Synergistically Ameliorates Nonalcoholic Steatohepatitis in HepG2 Cells
- (2017) Hyeong-Geug Kim et al. Evidence-based Complementary and Alternative Medicine
- Curcumin ameliorates liver damage and progression of NASH in NASH-HCC mouse model possibly by modulating HMGB1-NF-κB translocation
- (2017) Rejina Afrin et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Curcumin as a potential candidate for treating hyperlipidemia: A review of cellular and metabolic mechanisms
- (2017) Yunes Panahi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Turmeric Supplementation Improves Serum Glucose Indices and Leptin Levels in Patients with Nonalcoholic Fatty Liver Diseases
- (2017) Roya Navekar et al. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
- Efficacy and safety of turmeric and curcumin in lowering blood lipid levels in patients with cardiovascular risk factors: a meta-analysis of randomized controlled trials
- (2017) Si Qin et al. Nutrition Journal
- Curcumin improves alcoholic fatty liver by inhibiting fatty acid biosynthesis
- (2017) Chang Guo et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial
- (2017) Milad Daneshi-Maskooni et al. Trials
- Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol
- (2017) Seyed Ali Jazayeri-Tehrani et al. BMJ Open
- Does one size fit all? The role of body mass index and waist circumference in systemic inflammation in midlife by race and gender
- (2016) Irena Stepanikova et al. ETHNICITY & HEALTH
- Relations of Visceral and Abdominal Subcutaneous Adipose Tissue, Body Mass Index, and Waist Circumference to Serum Concentrations of Parameters of Chronic Inflammation
- (2016) Inga Schlecht et al. Obesity Facts
- Effect of curcumin on circulating interleukin-6 concentrations: A systematic review and meta-analysis of randomized controlled trials
- (2016) Giuseppe Derosa et al. PHARMACOLOGICAL RESEARCH
- Curcumin downregulates human tumor necrosis factor-α levels: A systematic review and meta-analysis ofrandomized controlled trials
- (2016) Amirhossein Sahebkar et al. PHARMACOLOGICAL RESEARCH
- Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial
- (2016) Yunes Panahi et al. INFLAMMOPHARMACOLOGY
- Curcumin, an active component of turmeric (Curcuma longa), and its effects on health
- (2015) Betül Kocaadam et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- Nesfatin-1 alleviates gastric damage via direct antioxidant mechanisms
- (2015) Meltem Kolgazi et al. JOURNAL OF SURGICAL RESEARCH
- AMPK-dependent modulation of hepatic lipid metabolism by nesfatin-1
- (2015) Yue Yin et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Regulatory neuropeptides (ghrelin, obestatin and nesfatin-1) levels in serum and reproductive tissues of female and male rats with fructose-induced metabolic syndrome
- (2014) Zekiye Catak et al. NEUROPEPTIDES
- Nesfatin-1 Stimulates Fatty-Acid Oxidation by Activating AMP-Activated Protein Kinase in STZ-Induced Type 2 Diabetic Mice
- (2014) Jing Dong et al. PLoS One
- Decreased levels of serum nesfatin-1 in patients with obstructive sleep apnea syndrome
- (2014) Peng Shen et al. Sleep and Breathing
- Molecular mechanisms of curcumin action: Signal transduction
- (2013) Adeeb Shehzad et al. BIOFACTORS
- A systematic review and meta-analysis of randomized controlled trials investigating the effects of curcumin on blood lipid levels
- (2013) Amirhossein Sahebkar CLINICAL NUTRITION
- Central nesfatin-1 influences the excitability of ghrelin-responsive gastric distension neurons in the arcuate nucleus and reduces gastric motility in rats
- (2013) Zhi-ling Li et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial
- (2013) Somlak Chuengsamarn et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
- (2012) Subash C. Gupta et al. AAPS Journal
- Curcumin Extract for Prevention of Type 2 Diabetes
- (2012) S. Chuengsamarn et al. DIABETES CARE
- Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects
- (2012) Adrian L Lopresti et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The anti-inflammatory and anti-apoptotic effects of nesfatin-1 in the traumatic rat brain
- (2012) Chong-Hui Tang et al. PEPTIDES
- Effects of Supplementation with Curcuminoids on Dyslipidemia in Obese Patients: A Randomized Crossover Trial
- (2012) Akram Mohammadi et al. PHYTOTHERAPY RESEARCH
- A novel appetite peptide, nesfatin-1 in patients with non-alcoholic fatty liver disease
- (2012) Ömer Başar et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Curcumin and Liver Cancer: A Review
- (2011) Altaf S. Darvesh et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- The association between the ratio of triglyceride to HDL-C and insulin resistance according to waist circumference in a rural Korean population
- (2011) H.-T. Kang et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Curcumin alleviates ethanol-induced hepatocytes oxidative damage involving heme oxygenase-1 induction
- (2010) Wei Bao et al. JOURNAL OF ETHNOPHARMACOLOGY
- Curcumin: From ancient medicine to current clinical trials
- (2008) H. Hatcher et al. CELLULAR AND MOLECULAR LIFE SCIENCES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started